Tetraphase to Host Conference Call on August 5th to Discuss Second Quarter 2015 Financial Results
29 juil. 2015 16h05 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., July 29, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Announces Appointment of Jacques Dumas, Ph.D. as Chief Scientific Officer
15 juil. 2015 09h19 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., July 15, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
01 juil. 2015 07h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., July 1, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present at Upcoming Conferences
16 juin 2015 08h30 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., June 16, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Reports First-Quarter 2015 Financial Results
06 mai 2015 16h01 HE
|
Tetraphase Pharmaceuticals, Inc.
Patient Enrollment Completed in IGNITE2, Phase 3 Clinical Trial of Eravacyline for cUTI
Company to Host Conference Call at 4:30 p.m. ET Today
WATERTOWN, Mass., May 6, 2015 (GLOBE NEWSWIRE) --...
Tetraphase to Host Conference Call on May 6th to Discuss First Quarter 2015 Financial Results and Recent Highlights
01 mai 2015 07h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., May 1, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Presents Detailed Results From Phase 3 Trials of Eravacycline at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
27 avr. 2015 07h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 27, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Appoints Gerri Henwood to Board of Directors
15 avr. 2015 17h15 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 15, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
15 avr. 2015 10h57 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 15, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH) today announced eight data presentations at the 25th European Congress of Clinical Microbiology and...
Tetraphase Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
07 avr. 2015 07h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 7, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...